(Reuters) - The U.S. Chamber of Commerce on Friday sued the federal government, challenging a new law that for the first time gives Medicare the power to negotiate drug prices with pharmaceutical ...
A lawyer for the U.S. Chamber of Commerce on Friday urged a federal judge to block President Joe Biden's administration from implementing a new program that would let Medicare negotiate prices with ...
Japanese drugmaker Astellas (OTCPK:ALPMF) has withdrawn a federal lawsuit that challenged the US government’s right to negotiate drug prices for its Medicare program, but maintained the newly ...
One year after IRA passage, bad actors try to thwart drug price negotiation, and Biden’s efforts to defend it fall short. Merck is suing the federal government over a plan to negotiate Medicare drug ...
The Biden administration has picked the first 10 high-priced prescription drugs subject to federal price negotiations, taking a swipe at the powerful pharmaceutical industry. It marks a major ...
President Joe Biden speaks during an event at the White House promoting lower health care costs on Aug. 29. The administration announced a list of the first 10 drugs subject to Medicare price ...
The maker of widely used blood thinner Eliquis on Friday sued the U.S. government over a provision in the Inflation Reduction Act that would let Medicare negotiate drug prices, becoming the second ...
All of the companies had drugs that made the list of the first 10 medications to be subject to Medicare price negotiations. PhRMA, a leading drug industry trade group, and the US Chamber of ...
Aug 31 (Reuters) - Drugmakers challenging a Biden administration program requiring them to negotiate with Medicare over the prices of selected costly drugs may not have a clear legal precedent on ...
“Congress knew that withdrawing all products from federal healthcare programs would be economic suicide—not a ‘real option.’” – U.S. Chamber motion for preliminary injunction On August ...
Analysis-Drugmakers Could Find Sympathetic US Supreme Court in Drug Pricing Lawsuits By Brendan Pierson (Reuters) - Drugmakers challenging a Biden administration program requiring them to ...
Your article was successfully shared with the contacts you provided. German pharmaceutical giant Boehringer Ingelheim is the latest company to sue the U.S. government over Medicare price ...
